Stay updated on Antihistamines in EoE Clinical Trial
Sign up to get notified when there's something new on the Antihistamines in EoE Clinical Trial page.

Latest updates to the Antihistamines in EoE Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a dedicated Locations section with the Florida site. Removed the HHS Vulnerability Disclosure and the Florida Locations item, and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedRevision label on the page footer updated from v3.2.0 to v3.3.2, with no changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the note about possible information delays due to a lapse in government funding and the operating-status guidance linked to opm.gov.SummaryDifference0.4%

- Check61 days agoChange DetectedNo significant changes detected between the old and new screenshots of the Study Details page for NCT04248712; the layout and core sections such as eligibility, interventions, outcomes, and study status appear unchanged.SummaryDifference0.5%

- Check90 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference5%

- Check97 days agoChange DetectedThe page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.SummaryDifference0.6%

Stay in the know with updates to Antihistamines in EoE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Antihistamines in EoE Clinical Trial page.